Cargando…
Risk-adapted monitoring is not inferior to extensive on-site monitoring: Results of the ADAMON cluster-randomised study
BACKGROUND: According to Good Clinical Practice, clinical trials must protect rights and safety of patients and make sure that the trial results are valid and interpretable. Monitoring on-site has an important role in achieving these objectives; it controls trial conduct at trial sites and informs t...
Autores principales: | Brosteanu, Oana, Schwarz, Gabriele, Houben, Peggy, Paulus, Ursula, Strenge-Hesse, Anke, Zettelmeyer, Ulrike, Schneider, Anja, Hasenclever, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718334/ https://www.ncbi.nlm.nih.gov/pubmed/28786330 http://dx.doi.org/10.1177/1740774517724165 |
Ejemplares similares
-
Assessing the potential for prevention or earlier detection of
on-site monitoring findings from randomised controlled trials: Further analyses
of findings from the prospective TEMPER triggered monitoring
study
por: Cragg, William J, et al.
Publicado: (2020) -
Impact of retrospective data verification to prepare the ICON6 trial
for use in a marketing authorization application
por: Embleton-Thirsk, Andrew, et al.
Publicado: (2019) -
Clinical Research in the Time of COVID-19
por: Felix, Carol
Publicado: (2020) -
Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology
por: Gensheimer, Michael F., et al.
Publicado: (2020) -
Life After COVID-19 for Cancer Clinical Trials
por: Hall, Emma, et al.
Publicado: (2020)